Ameriprise
DSCI

Ameriprise’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Ameriprise’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-20
Closed – – 6168
2014
Q2 		$0 Buy
+20
New +$205 ﹤0.01% 5968
2013
Q4 		– Sell
-854
Closed -$11K – 5934
2013
Q3 		$11K Hold
854
– – ﹤0.01% 4883
2013
Q2 		$11K Buy
+854
New +$11K ﹤0.01% 4750

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Ameriprise's DSCI Position: Q3 2014 in Review

Ameriprise sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q3 2014, closing a stake of 20 shares.

Ameriprise first reported a position in DSCI in Q2 2013 and held it in 3 quarters. The position peaked at $11K in Q3 2013. 70 funds tracked by Wall St. Rank hold DSCI as of Q3 2014.

  • Ameriprise reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q3 2014 after selling out during the quarter.
  • Ameriprise sold 20 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2014.
  • Ameriprise first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 3 quarters.
  • Ameriprise's Derma Sciences, Inc. Common Stock (DE) position peaked at $11K in Q3 2013.
  • 70 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2014.

Based on Ameriprise's 13F filing for Q3 2014, filed 14 Nov 2014.